EBASTINE 20mg. IP

A long-acting, nonsedating second-generation antihistamine that treats allergic disorders with moderate and severe allergic symptoms. (Paul Van Cauwenberge, 2004) Possesses a rapid onset of action and long-lasting inhibition of histamine-induced effect. (Luria, 1999) Effectively relieves the nasal and non-nasal symptoms of seasonal and perennial allergic rhinitis. (Luria, 1999) An effective and well-tolerated alternative to other second generation antihistamines for the treatment of seasonal and perennial allergic rhinitis and chronic idiopathic urticaria. (L R Wiseman, 1996) A valuable treatment option for patients with allergic rhinitis or chronic idiopathic urticaria. (M Hurst, 2000) Significantly reduces both wheal and flare responses to allergens. (Ciprandi, 2010) Induces a greater decrease in rhinitis symptom than loratadine 10 mg in seasonal allergic rhinitis patients. (Paul Ratner, 2005) A potent therapeutic agent that is more efficient in the control of symptoms (rhinorrhea, nasal obstruction, sneezing, eye and nose itching) than terfenadine. (L Terán Ortíz, 1993)